The Wuhan Institute of Virology, China Academy of Sciences had filed a patent application to use remdesivir to treat the novel coronavirus (2019 nCoV) on January 21, 2020, which has sparked debate on China’s social media about intellectual property issues. The company said it had filed patent applications for the drug’s use on coronaviruses in China and some other countries and regions in 2016, but it has not yet received Read More …
